We are developing a pipeline of prescription drug product candidates and non-prescription products to address unmet needs in animal health.
Canalevia™ is our lead prescription drug product candidate for the treatment of various forms of diarrhea in dogs. Canalevia is a canine-specific formulation of crofelemer, an active pharmaceutical ingredient isolated and purified from the Croton lechleri tree. Jaguar has received Minor Use in a Major Species (MUMS) designation for Canalevia for Chemotherapy-Induced Diarrhea (CID) in dogs.
Neonorm™ Calf is our non-prescription product to help dairies and beef farms proactively retain fluid in calves—helping the animals avoid debilitating, dangerous levels of dehydration (learn more). Neonorm is a botanical extract derived from the Croton lechleri tree.
Our product pipeline leverages the data and knowledge our team has gained during the development from human therapeutics into veterinary applications.